Social media giant Facebook on Thursday reported $1.80 in earnings per share on $18.69 billion in revenue compared to analysts' consensus estimate calling for $1.39 in EPS and $17.4 billion in revenue.
Johnson & Johnson has announced that it will launch its human study for its lead vaccine candidate in the United States and Belgium.
Kraft Heinz reported better than expected second-quarter financial results before the markets opened on Thursday, but shares fell anyway.
Edesa Biotech joins the list of COVID-19 stocks, as the company is making headway with regulatory agencies for its late-stage study. Investors were quick to give this firm the coronavirus bump, more than doubling…
Procter & Gamble reported better than exepcted fiscal fourth-quarter financial results before the markets opened on Thursday.
Digital payment firm PayPal reported $1.07 in earnings per share (EPS) and $5.26 billion in revenue in the second quarter, compared with consensus estimates that called for $0.88 in EPS on $4.99 billion in…
L Brands surged on Wednesday to a new 52-week high after the company unveiled a new cost-cutting strategy that it will employ.
Cybersecurity firm FireEye saw record numbers in its most recent quarter as COVID-19 has placed much more emphasis on the industry.
Shopify stock rallied after the e-commerce company reported better than expected quarterly results before the opening bell on Wednesday.
Spotify Technology reported disappointing second-quarter financial results before the markets opened on Wednesday, despite solid user growth in the period.
Starbucks reported a net loss of $0.46 per share and $4.2 billion in revenue for its fiscal third quarter, compared with consensus estimates that called for a net loss of $0.59 per share and…
Spectrum Pharmaceuticals announced good news for lung cancer patients in its midstage trial on Tuesday.
Personal finance and consumer service firm Rocket Companies has filed with the SEC for its initial public offering.
Altria reported better than expected quarterly results and re-established its 2020 full-year earnings guidance before the markets opened on Tuesday.
Pfizer released a better than expected second-quarter earnings report and increased its guidance before the markets opened on Tuesday.
3M released disappointing second-quarter financial results before the markets opened on Tuesday
Pfizer and BioNTech made another big step in their fight against COVID-19 by initiating their late-stage study for their lead mRNA vaccine candidate.
Schultze Special Purpose Acquisition has announced that it will combine with Clever Leaves International to operate under the name Clever Leaves.
MediciNova saw the coronavirus bump on Monday after it said it had entered a worldwide exclusive agreement with BioComo for the rights to develop a SARS-CoV-2 vaccine.
Technology services company Rackspace intends to price more than 33 million shares to result in an initial public offering valued at over $924 million.
